FBI Court Docs Reveal Comey’s Memos Contained Classified

New Post Public Reply Private Reply Replies (1) Message Board
Lmcat
177
FBI Court Docs Reveal Comey’s Memos Contained Classified Information – Including Name of Confidential Source Used Against Trump

4d740b50949ff85176fbc0d005b7e0d9-fbi-director-james-comey-600x450.jpg

Newly released FBI court docs confirm James Comey was indeed a witness in the Mueller investigation and his Trump memos were of interest in the special counsel probe.

“The FBI and the Special Counsel’s office have determined that disclosure of the Comey Memos … could reasonably be expected to adversely affect the pending Russia investigation. The Comey Memos are his contemporaneous notes about incidents that are of interest in that investigation …”

According to the court filing released late Monday, Comey’s memos contained classified information (contrary to Comey’s claims), including the name [redacted] of the confidential source the FBI used against Trump.

The documents also suggest then-FBI Director James Comey began his coup against President Trump because he didn’t like his foreign-policy decision making.

The documents were released as part of a FOIA lawsuit filed by Judicial Watch, CNN, USA Today and others against the FBI in an effort to make Comey’s Trump memos public.

A couple weeks ago, US District Judge James Boasberg in Washington ordered the FBI to turn over Comey’s ‘Trump memos’ — both clean and redacted versions by April 1st as he weighed releasing them to the public.

The FBI previously pushed back on March 1st and wrote to Judge Boasberg, an Obama appointee, saying that the memos were still redacted and classified and should remain under seal to avoid interfering with Mueller’s inquisition — Mueller’s witch hunt ended a few weeks ago so the judge asked the FBI to file an opinion about the release of Comey’s memos.

David Archey, the lead FBI investigator for Mueller’s witch hunt told the court that since the special counsel investigation has concluded, portions of Comey’s memos can be released — David Archey informed the court that material from Comey’s memos will continue to remain under seal and redacted.


The FBI will file a further declaration on or before April 15, 2019, to explain why the remaining redactions to the Third Archey Declaration continue to be necessary.

-REWIND-

Then- FBI Director James Comey personally signed off on THREE FISA applications to spy on Trump campaign advisor Carter Page — one of the FISA warrants Comey signed off on was after he met with President-elect Trump on January 6th, 2017 (at Trump Tower), with the intent of putting the incoming administration under a cloud of suspicion with an investigation and criminal leaks to the media.

President Trump fired Comey as FBI Director on May 9th, 2017 and Comey immediately went into overdrive to launch a special counsel probe into the president as revenge.

Comey admitted during a Congressional hearing that he gave portions of his memos to a friend to leak to the New York Times in order to prompt a special counsel investigation into President Trump for obstruction of justice.

Within 24 hours of the memo leak to the New York Times, Mueller was appointed as special counsel on May 17th, 2017 — when exactly did Comey share his memos with Robert Mueller?


Now it is confirmed that Comey was a witness in Mueller’s probe… Did Mueller give his buddy Comey immunity?

Newly released FBI court documents suggest that Comey and others launched their coup against President Trump because they didn't like his "foreign-policy decision making."

The documents also reveal that Comey included classified information in his memos. https://t.co/ZbglI2XZIg pic.twitter.com/Pgye82Yx1b

— Sean Davis (@seanmdav) April 9, 2019

You can read the full court filing about Comey’s memos here.

https://www.scribd.com/document/405516262/FBI...omey-Memos

https://www.thegatewaypundit.com/2019/04/fbi-...06:10%20PM

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 256

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 194

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 20

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading

Top 5 Most Recently Viewed Articles

Academy Sports + Outdoors Teams Up to Empower Military Families

Updated Category News Views 142

Academy Sports + Outdoors Supports Military Families This School Year In an inspiring initiative aimed at supporting military families, Academy Sports + Outdoors has partnered with Operation Homefront to provide essential school supplies for students heading back to class. As the back-to-school season approaches, these organizations are ensuring that military children...

Continue Reading
Repligen Corp's Q4 Earnings Reflect Strong Market Momentum

Updated Category News Views 232

Repligen Corp Highlights Strong Q4 Performance Repligen Corp (NASDAQ: RGEN) has recently reported its fourth-quarter earnings, showcasing an adjusted EPS of 44 cents. This is a slight decrease compared to the previous year's 48 cents but notably beats analysts’ consensus estimates of 41 cents. Sales Performance and Market Outlook The company reported sales hitting...

Continue Reading
Propanc Biopharma's Fiscal Year Highlights and Future Plans

Updated Category News Views 130

Propanc Biopharma's Recent Developments and Strategic Vision Propanc Biopharma, Inc. (NASDAQ: PPCB), a biopharmaceutical firm centered on innovations in cancer treatment, recently shared its year-end updates and strategic plans. As the financial year concluded on June 30, 2025, notable gains in the Company’s financial health have paved the way for exciting advancements....

Continue Reading
MIAX Strengthens Leadership with Key Executive Appointments

Updated Category News Views 253

MIAX Expands Leadership Team to Drive Market Growth Miami International Holdings, Inc. (NYSE: MIAX) is excited to unveil the new appointments of Shelly Brown and Joseph W. Ferraro III as part of its commitment to strategic growth in the futures market. These moves are aimed at enhancing leadership within MIAX Futures™, a core component of its expanding offerings in...

Continue Reading
Fortis Inc. Declares Upcoming Dividends for Shareholders

Updated Category News Views 137

Fortis Inc. Announces Upcoming Shareholder Dividends Fortis Inc. has officially declared dividends that are set to benefit its shareholders on March 1, 2025. This announcement is a key development for shareholders holding various classes of shares with specific dividends attached. The established record date for these dividends is February 18, 2025, marking an important...

Continue Reading